Our medical science would be so advanced that we’d be able to be treated for broken and lost teeth that re-growing them would be done in a few days. We would get over the stigma of religious resistance and be allowed to grow organs that’d be just as good as the ones we’re born with so transplants can be systematically easier.
We would artificially be immortal. We could still die in some ways, so we’re not purely immortal, but we’d be able to overcome so many obstacles for our health never before seen.
Yes, I think the profit-driven logic prevents innovation and compassion, especially in the medical field: Hardly any medical technology company conducts research on rare diseases, and no pharmaceutical company would ever forgo profits in order to heal people.
Instead, these billion-dollar behemoths buy up patents from startups that, as university spin-offs, received substantial public funding. These patents are sometimes not even used at all, as they were purchased solely to prevent them from interfering with profitable products - and it’s not even a matter of which approach is better: This is irrelevant to the leadership of these corporations, since they are concerned exclusively with profit.
Our medical science would be so advanced that we’d be able to be treated for broken and lost teeth that re-growing them would be done in a few days. We would get over the stigma of religious resistance and be allowed to grow organs that’d be just as good as the ones we’re born with so transplants can be systematically easier.
We would artificially be immortal. We could still die in some ways, so we’re not purely immortal, but we’d be able to overcome so many obstacles for our health never before seen.
And healthcare would be affordable on top of it.
Yes, I think the profit-driven logic prevents innovation and compassion, especially in the medical field: Hardly any medical technology company conducts research on rare diseases, and no pharmaceutical company would ever forgo profits in order to heal people.
Instead, these billion-dollar behemoths buy up patents from startups that, as university spin-offs, received substantial public funding. These patents are sometimes not even used at all, as they were purchased solely to prevent them from interfering with profitable products - and it’s not even a matter of which approach is better: This is irrelevant to the leadership of these corporations, since they are concerned exclusively with profit.